Intercept’s Ocaliva approved in EU for liver diseasePotential liver blockbuster gets EU licence. Share XIntercept’s Ocaliva approved in EU for liver diseasehttps://pharmaphorum.com/news/intercepts-ocaliva-approved-eu-liver-disease/